Camac Capital, LLC, Insider at Pasithea Therapeutics Corp. (KTTA), bought 22,828 shares at $1.17 ($26K) on 2022-08-29, disclosed to the SEC on 2022-08-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.17 | 5,000 | $6K | 22.2% |
| 2 | $1.15 | 17,828 | $21K | 77.8% |
| Total | $1.15 avg | 22,828 | $26K | 100% |
| Filing → |